Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia
Muhammad Youshay Jawad, Shakila Meshkat, Aniqa Tabassum, et al.
CNS Spectrums (2022) Vol. 28, Iss. 5, pp. 541-560
Closed Access | Times Cited: 22

Showing 22 citing articles:

Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 44
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S. McIntyre
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 5, pp. 539-542
Open Access | Times Cited: 16
Psychosocial risks in Metabolic dysfunction-associated steatotic liver disease
Hanne Åström, Christine Takami Lageborn, Hannes Hagström
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access | Times Cited: 1
Non-alcoholic fatty liver disease causally affects the brain cortical structure: a Mendelian randomization study
Yu‐Kai Lin, Xinran Cai, Jiang-Zhi Chen, et al.
Frontiers in Neuroscience (2024) Vol. 17
Open Access | Times Cited: 6
The Co-occurrence of Depression and Obesity
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 6
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®)
Roger S. McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat, et al.
Journal of Affective Disorders (2024)
Open Access | Times Cited: 5
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis
Angela T.H. Kwan, Moiz Lakhani, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 390-396
Closed Access
Exploring the mechanism of SLXG for treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking
Yang Wang, Jiaxing Wang, Zitong Chen, et al.
Medicine (2025) Vol. 104, Iss. 6, pp. e40255-e40255
Open Access
Treating obesity in patients with depression: a narrative review and treatment recommendation
Pamela Kushner, Scott Kahan, Roger S. McIntyre
Postgraduate Medicine (2025)
Closed Access
HIIT may ameliorate inter-organ crosstalk between liver and hypothalamus of HFD-induced MAFLD rats; A two-phase study to investigate the effect of exercise intensity as a stressor
Mohammad Ali Sardar, Sadegh Abbasian, Hamid Moghavemi, et al.
Brain Research (2025), pp. 149591-149591
Closed Access
The Behavioral and Neuroinflammatory Impact of Ketamine in a Murine Model of Depression and Liver Damage
Mădălina Iuliana Mușat, Ana-Maria Ifrim-Predoi, Smaranda Ioana Mitran, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3558-3558
Open Access
The Role of the Stress Response in Metabolic Dysfunction-Associated Fatty Liver Disease: A Psychoneuroendocrineimmunology-Based Perspective
Ilaria Demori, Elena Grasselli
Nutrients (2023) Vol. 15, Iss. 3, pp. 795-795
Open Access | Times Cited: 10
Patient Reported Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease
Aurora Barberá, Trenton M. White, Anish Arora, et al.
Seminars in Liver Disease (2024)
Closed Access | Times Cited: 2
A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain
Trisha Menon, Serene M. L. Lee, Xiaowen Gong, et al.
CNS Spectrums (2024) Vol. 29, Iss. 5, pp. 347-353
Open Access | Times Cited: 2
Effects of ketamine on metabolic parameters in depressive disorders: A systematic review
Sabrina Wong, Gia Han Le, Rodrigo B. Mansur, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 164-173
Open Access | Times Cited: 1
Association of depressive symptoms with chronic liver disease among middle-aged and older adults in China
Jingke Zeng, Xiaohuan Lai, S.-M. Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2
The Impact of NAFLD-Related Indices on Brain Structure: Insights from Mendelian Randomization and Colocalization Analysis
Chong Chen, Yugang Fu, S. Q. Gu, et al.
(2024)
Closed Access
Sleep Apnea in Schizophrenia: Estimating Prevalence and Impact on Cognition
Stephen Edward Ghazikhanian, Toral Surti
Journal of Psychiatric Research (2024) Vol. 177, pp. 330-337
Closed Access
Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 10, pp. 936-937
Closed Access
Effect of Cariprazine on Anhedonia in Patients with Bipolar I Depression: Post Hoc Analysis of Three Randomized Placebo-Controlled Clinical Trials
Roger S. McIntyre, Pierre‐Michel Llorca, Lauren C. Aronin, et al.
Advances in Therapy (2024) Vol. 42, Iss. 1, pp. 246-260
Open Access
Assessment of cognitive function in patients with metabolic dysfunction-associated steatotic liver disease
O.Y. Komarytsia, О. М. Радченко, Zoriana Huk-Leshnevska, et al.
INTERNATIONAL NEUROLOGICAL JOURNAL (2024) Vol. 20, Iss. 7, pp. 343-346
Open Access
Mood instability and risk of gastrointestinal diseases - a univariable and multivariable mendelian randomization study
Ruilin Liu, Qian Song, Liming Liu, et al.
Annals of General Psychiatry (2024) Vol. 23, Iss. 1
Open Access
Page 1

Scroll to top